- Home
- KNSA vs FINV Comparison
KNSA vs FINV Comparison
Compare KNSA & FINV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- FINV
- Stock Information
- Founded
- KNSA 2015
- FINV 2007
- Country
- KNSA United Kingdom
- FINV China
- Employees
- KNSA N/A
- FINV N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- FINV Finance: Consumer Services
- Sector
- KNSA Health Care
- FINV Finance
- Exchange
- KNSA Nasdaq
- FINV Nasdaq
- Market Cap
- KNSA 1.7B
- FINV 1.7B
- IPO Year
- KNSA 2018
- FINV N/A
- Fundamental
- Price
- KNSA $20.59
- FINV $6.81
- Analyst Decision
- KNSA Strong Buy
- FINV
- Analyst Count
- KNSA 5
- FINV 0
- Target Price
- KNSA $36.60
- FINV N/A
- AVG Volume (30 Days)
- KNSA 290.2K
- FINV 868.9K
- Earning Date
- KNSA 10-29-2024
- FINV 11-18-2024
- Dividend Yield
- KNSA N/A
- FINV 3.50%
- EPS Growth
- KNSA N/A
- FINV N/A
- EPS
- KNSA N/A
- FINV 1.19
- Revenue
- KNSA $384,098,000.00
- FINV $1,837,029,436.00
- Revenue This Year
- KNSA $60.05
- FINV $6.61
- Revenue Next Year
- KNSA $36.32
- FINV $7.72
- P/E Ratio
- KNSA N/A
- FINV $5.70
- Revenue Growth
- KNSA 54.41
- FINV 2.92
- 52 Week Low
- KNSA $16.56
- FINV $4.45
- 52 Week High
- KNSA $28.15
- FINV $7.29
- Technical
- Relative Strength Index (RSI)
- KNSA 40.95
- FINV 53.69
- Support Level
- KNSA $19.97
- FINV $6.68
- Resistance Level
- KNSA $20.85
- FINV $7.15
- Average True Range (ATR)
- KNSA 0.69
- FINV 0.21
- MACD
- KNSA 0.03
- FINV -0.03
- Stochastic Oscillator
- KNSA 35.61
- FINV 15.62
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About FINV FinVolution Group
FinVolution Group is a provider of online consumer finance in China. It offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers Tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company provides investors with an opportunity to invest in emerging asset class-consumer loans through a variety of investment options. It generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC and its revenues are derived from within the PRC.